Association of patient and clinical factors with CIPN
peripheral neuropathy, CIPN
PERIPHERAL NEUROPATHY
ANCOVA results (ANCOVA for the effect of age, sex, BMI, chemotherapy regimen (CAPOX versus FOLFOX), baseline PN, and oxaliplatin dose on acute and long-term CIPN from 3 to 24 monthsMultivariate models are adjusted for the randomisation arm. The cut-off for statistical significance was set at <0.01 to account for multiple testing.ANCOVA, analysis of covariance; BMI, body mass index; CAPOX, capecitabine with oxaliplatin; CIPN, chemotherapy-induced peripheral neuropathy; FOLFOX, fluorouracil with oxaliplatin; PN, peripheral neuropathy.Statistical significance.In addition, baseline peripheral neuropathy was associated with peripheral neuropathy scores during and after treatment (